Technology Core

技术核心

基本信息

批准号：
10735582
负责人：
Nathaniel Scott Hafer
金额：
$ 80.19万
依托单位：
UNIV OF MASSACHUSETTS MED SCH WORCESTER
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-01 至 2028-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10735582
关键词：
Address Affect Award Businesses Caregivers Caring Clinic Clinical Clinical Research Collaborations Collection Communities Development Device or Instrument Development Devices Diagnosis Disease Engineering Ensure Evaluation Funding Goals Grant Health Sciences Health system Healthcare Heart Diseases Hematological Disease Home Incubators Industry Inpatients Intellectual Property Letters Lung diseases Marketing Massachusetts Medical Medical Device Minority Groups Monitor Morbidity - disease rate National Heart, Lung, and Blood Institute Needs Assessment Outcome Patients Performance Point of Care Technology Process Provider Quality of Care Resource-limited setting Resources Services Sleep Disorders Source Technology Testing Underserved Population Universities Validation Work commercialization cost data integration design digital health health care disparity health disparity health management implementation science improved medical schools member mortality new technology novel operation point of care prototype social health determinants success technological innovation technology development tool usability

项目摘要

Project Summary/Abstract – Technology Core The goal of the Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders (HLBS) is to develop and optimize novel point of care technologies (POC) and home-based technologies to improve the diagnosis and treatment of HLBS disorders, especially those targeted for low resource settings. HLBS disorders collectively represent the single greatest source of morbidity and mortality in the US, and they disproportionately affect minoritized and underserved populations. New POC and home-based technologies are critical enablers of the ongoing transformation of healthcare, which is moving out from specialized inpatient testing facilities into the clinic and the home. CAPCaT was originally based on the highly successful medical product incubator, the Massachusetts Medical Device Development Center (M2D2), at the University of Massachusetts (UMass) Lowell and UMass Chan campuses. UMass Lowell has strengths in engineering and business, while the Worcester campus houses the UMass Chan Medical School, the first and only public academic health system in the Commonwealth of Massachusetts. Over the past five years, CAPCaT has conducted four national calls for applications and from 441 applicants has selected, awarded, monitored, and comprehensively supported 23 HLBS POC innovations. CAPCaT awardees have raised over $43M in funding, refined/developed new products, generated 9 new intellectual properties, and brought new technologies to market. In this competitive renewal, the Technology Core of CAPCaT will continue to issue broad-reaching calls for applications and will select and support new meritorious projects focusing on later-stage POC and home- based technologies from across the HLBS space. Selection will be based on performance and potential for clinical impact, likelihood of implementation and addressing an HLBS health disparity. CAPCaT’s Technology Core will support selected projects utilizing a strong collection of existing resources at UMass Lowell and UMass Chan to help further develop and refine later-stage prototypes to the point of validation and user-testing.

项目总结/摘要——技术核心心脏、肺、血液和睡眠护理点技术推进中心 (CAPCaT) 的目标 Disorders (HLBS) 旨在开发和优化新颖的护理点技术 (POC) 和家庭护理技术改进 HLBS 疾病的诊断和治疗的技术，特别是针对低血压的疾病 HLBS 疾病总体上是发病率和死亡率的最大来源。美国，它们对少数族群和服务不足的人群产生了不成比例的影响。技术是医疗保健持续转型的关键推动者，医疗保健正在从 CAPCaT 最初是基于高度的住院检测设施进入诊所和家庭。成功的医疗产品孵化器，马萨诸塞州医疗器械开发中心 (M2D2)，位于马萨诸塞大学 (UMass) 洛厄尔校区和 UMass Chan 校区在以下方面具有优势。工程和商业，而伍斯特校区则设有麻省大学陈医学院，这是第一所也是过去五年来，CAPCaT 是马萨诸塞州唯一的公共学术医疗系统。已进行四次全国性申请征集，并从 441 名申请者中筛选、授予、监督、并全面支持 23 项 HLBS POC 创新项目，已筹集超过 4300 万美元。资金，完善/开发新产品，产生9项新知识产权，并带来新技术在这次竞争更新中，CAPCaT 的技术核心将继续发布影响广泛的产品。征集申请，并将选择和支持新的优秀项目，重点关注后期POC和家庭- 整个 HLBS 领域的技术选择将基于性能和潜力。解决 HLBS 健康差异问题的临床影响、可能性和实施。 Core 将利用麻省大学洛厄尔分校和麻省大学现有的强大资源来支持选定的项目 Chan 帮助进一步开发和完善后期原型以进行验证和用户测试。